Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational ...
The Oneonta Common Council reviewed, but did not express concerns with, an application for a liquor license at a Chestnut ...
Agreement includes supply of Cabot’s conductive carbons and dispersions for lithium-ion battery applications BOSTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT), a global leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback